biostudies-literatureUnknown399(10323)Attard GSwiss Group for Clinical Cancer ResearchJanssen LPCancer Research UKMedical Research CouncilNational Institute for Health Research (NIHR)Astellas Pharma IncLancet (London, England)447-460https://www.ebi.ac.uk/biostudies/studies/S-EPMC8811484biostudies-literatureAbiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.PMC881148438041251828284NF-SI-0611-1010619727NF-SI-0617-10099MC_UU_12023/25MC_UU_00004/0122744John HBrawley CTanguay JSheehan DSmith-Howell MSyndikus IFackrell DBerthold DNarahari KVilarino-Varela MRobson PParmar MKBDouglas FBloomfield DKagzi MAhmed ITaylor HHughes RSabharwal APereira Mestre RThalmann GMasters BSreenivasan TMason MDConroy RBahl AAttard GSystemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigatorsBorner MJames NDChan APaisey SShaffer RWylie JIbrahim AStrebel RCook AHoskin PBrock SDurr DDealey RHofmann USundar SPedley INikapota APorfiri EThomas CSydes MRLee LParikh OJones ECross WPugh CFalconer AMelcher LDearnaley DPPerna CSayers IBirtle ATipples KGillessen SGlen HCarser JKhan MMSivoglo VTran ARudman SMullessey VCrabb SMatheson DAzzabi AGray EAfshar MHingorani MMcPhail NLogue JParker CCBrown LCWoodward CGilson CGibbs SSrihari NSidek NBeyer JJones RJSangar VMullassery VHamid AShaheen APorter TSimms MBrulinski PProtheroe AGupta NRoggero ELydon AAlzoueb MAmos CLPhan MDGilbert DBuckner MRentsch CEngeler DHyde KClarke NWMcGovern UGraham JVengalil SRush HBhalla NRussell JMBowen JHilman SVivekanandan SKhan Yde Bono JSChowdhury SBeresford MDas PAlameddine MBrierly RWagstaff JRogers PZarkar ABoussios SMurphy LLeaning DCapaldi LPopescu RMillman RWalker GGrant WPeedell CO'Sullivan JMMcLaren DGale JAtako NLangley REWorlding JWhelan PJoseph JPezaro CRobinson AMazhar DKhoo VNeedleman SFord DKhan OKeng-Koh PMalik ZKumar ABrown SMuthukumar DManetta CTarver KfalseAbiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.2022-01-01T00:00:00Z2022 Jan2026-05-31T05:01:23.361Z2025-02-19T01:53:37.691ZS-EPMC88114843495352510.1016/S0140-6736(21)02437-5